Tabraiz Mohammed to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Tabraiz Mohammed has written about Histone Deacetylase Inhibitors.
Connection Strength
0.096
-
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist. 2011; 16(6):835-43.
Score: 0.096
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.